Skip to main content
Premium Trial:

Request an Annual Quote

Biotique Grabs Rights to DoubleTwist Software

SAN FRANCISCO, July 29 - Biotique Systems said today it has obtained worldwide exclusive rights from the University of Houston for software formerly offered by defunct bioinformatics shop DoubleTwist.

 

Biotique, of Emeryville, Calif., will now have access to the d2, d2 cluster, and CRAW software platforms that powered DoubleTwist's clustering and alignment tools. Neither the school nor Biotique disclosed the terms of the agreement.

 

"We started the process as soon as we heard DoubleTwist was closing its doors," Biotique Systems CEO Stephen Sanders told GenomeWeb in an e-mail. "We were close to the more than 30 customers for DoubleTwist's clustering and alignment tools and wanted to ensure that [the customers] received continuity for their use of this technology."

 

Sanders said the new software, which also is used as the base source code for South Africa-based Electric Genetics' STACK PACK programs, will complement Biotique's core Local Integration System platform for analyzing the human genome for drug-target discovery.

 

The d2 and CRAW software, co-developed at the University of Houston by Biotique co-founder and former DoubleTwist vice president of bioinformatics John Burke, enables clustering and alignment of mRNA and EST sequences.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.